Allocca M - Search Results

1

The gut-brain axis: Correlation of choroid plexus volume and permeability with inflammatory biomarkers in Crohn's disease.

Bonifacio C, Savini G, Reca C, Garoli F, Levi R, Vatteroni G, Balzarini L, Allocca M, Furfaro F, Dal Buono A, Armuzzi A, Danese S, Matteoli M, Rescigno M, Fiorino G, Politi LS. Bonifacio C, et al. Among authors: allocca m. Neurobiol Dis. 2024 Mar;192:106416. doi: 10.1016/j.nbd.2024.106416. Epub 2024 Jan 23. Neurobiol Dis. 2024. PMID: 38272141 Free article.

2

Commentary: antibodies reacting with the infliximab Fab portion--something new?

Allocca M, Fiorino G, Danese S. Allocca M, et al. Aliment Pharmacol Ther. 2013 Sep;38(5):552. doi: 10.1111/apt.12401. Aliment Pharmacol Ther. 2013. PMID: 23937461 No abstract available.

3

Cross-sectional imaging modalities in Crohn's disease.

Allocca M, Fiorino G, Danese S. Allocca M, et al. Dig Dis. 2013;31(2):199-201. doi: 10.1159/000353692. Epub 2013 Sep 6. Dig Dis. 2013. PMID: 24030225 Review.

4

Anti-IL-6 treatment for inflammatory bowel diseases: next cytokine, next target.

Allocca M, Jovani M, Fiorino G, Schreiber S, Danese S. Allocca M, et al. Curr Drug Targets. 2013 Nov;14(12):1508-21. doi: 10.2174/13894501113146660224. Curr Drug Targets. 2013. PMID: 24102406 Review.

5

Commentary: anaemia in inflammatory bowel disease--the most common and ignored extra intestinal manifestation.

Fiorino G, Allocca M, Danese S. Fiorino G, et al. Among authors: allocca m. Aliment Pharmacol Ther. 2014 Jan;39(2):227-8. doi: 10.1111/apt.12578. Aliment Pharmacol Ther. 2014. PMID: 24330239 No abstract available.

6

Complementary and alternative medicine in inflammatory bowel diseases: what is the future in the field of herbal medicine?

Gilardi D, Fiorino G, Genua M, Allocca M, Danese S. Gilardi D, et al. Among authors: allocca m. Expert Rev Gastroenterol Hepatol. 2014 Sep;8(7):835-46. doi: 10.1586/17474124.2014.917954. Epub 2014 May 12. Expert Rev Gastroenterol Hepatol. 2014. PMID: 24813226 Review.

7

Blockade of lymphocyte trafficking in inflammatory bowel diseases therapy: importance of specificity of endothelial target.

Allocca M, Fiorino G, Vermeire S, Reinisch W, Cataldi F, Danese S. Allocca M, et al. Expert Rev Clin Immunol. 2014 Jul;10(7):885-95. doi: 10.1586/1744666X.2014.917962. Epub 2014 May 12. Expert Rev Clin Immunol. 2014. PMID: 24813675 Review.

8

Review article: optimal preparation for surgery in Crohn's disease.

Spinelli A, Allocca M, Jovani M, Danese S. Spinelli A, et al. Among authors: allocca m. Aliment Pharmacol Ther. 2014 Nov;40(9):1009-22. doi: 10.1111/apt.12947. Epub 2014 Sep 10. Aliment Pharmacol Ther. 2014. PMID: 25209947 Review.

9

Iron deficiency: the hidden miscreant in inflammatory bowel disease.

Allocca M, Fiorino G, Danese S. Allocca M, et al. Curr Drug Targets. 2014;15(11):1011-9. doi: 10.2174/1389450115666140909150850. Curr Drug Targets. 2014. PMID: 25213175 Review.

10

New targeted therapies such as anti-adhesion molecules, anti-IL-12/23 and anti-Janus kinases are looking toward a more effective treatment of inflammatory bowel disease.

Bravatà I, Fiorino G, Allocca M, Repici A, Danese S. Bravatà I, et al. Among authors: allocca m. Scand J Gastroenterol. 2015 Jan;50(1):113-20. doi: 10.3109/00365521.2014.993700. Scand J Gastroenterol. 2015. PMID: 25523561 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

215 results

Search Page

Filters